Multiple Myeloma Foundation: MMRF

Multiple myeloma foundation - Multiple Myeloma Research Foundation (MMRF) - Multiple myeloma is a cancer of the plasma cells in the bone marrow, proteins that form antibodies. Cancer or malignant plasma cell is called cell myeloma. Myeloma is called "multiple" because there often occurs a few neoplastic or areas in the bones where they grow. It can occur as like a tumor, and as the area of loss of bone mass and affects the places where bone marrow is active in an adult: a hollow area within the bones of the spine, skull, pelvis, thoracic skin and the area Around the shoulders and hips.
Multiple Myeloma Foundation

I'm part of a radio broadcast of the Cure Talk within a few hours of presenting the co-founder of the Foundation for research of myeloma Anne Quinn Young. If you can't listen live, by passing the link will listen later.

Here is a short overview about the show:

Multiple Myeloma Foundation: MMRF

In 2015 in the world of myeloma appeared a lot of events. Four new drugs were approved by FDA, thus increasing treatment options and allow the new combined modes; Promising results of the research of immunotherapy show that these results have been used in clinical practice and 1000 patients with myeloma were enrolled in the study, CoMMpass MMRF.

We're talking with Anne Quinn Young of the MMRF, in order to understand the importance of progress in the research of myeloma in 2015 for myelomovou patient community, as well as evaluate the research initiatives of the MMRF in the last year and what patients can expect in the coming new year.

We go at 6 pm eastern standard time. Here's a number you can call to listen or ask questions:

If you read it before the 18th hour, you can leave a comment and be sure about it I'll ask Anna.

Anne and I, we started to develop a friendship, when I met with her on a media panel in Boston about six or seven years ago. It's a relentless worker. Very bright.

I'll ask her if she has a feel for which of the dozens of possible next generation of myeloma therapies that are being studied, they think that they will be approved as the first? More importantly, what they think, that will probably work best? Anne knows about the problems with the quality of life that face patients with myeloma, because we live longer. I think it's been more than ten years. I should ask her. It's like asking a woman her age? Maybe I should: you look so youthful in the picture, which I had on the list, Anne! Feel good and keep smiling!